Eight years ago, Orthopedic Surgeon Dr. William Kapp attended a medical conference that changed his professional life.
He had gone from a private practice doctor to co-establish a company that set up critical care hospitals to then sell this company. He gave him interest in both sides of health care: medicine and business aspects, he told TechCrunch.
So he went to the annual conference hosted by the famous Dr. Daniel Kraft to find out about new technology that could improve the results while reducing costs. Dr. Peter Diamandis, founder and president of the XPrize Foundation, was on stage that year with Dr. Bob Hariri, pioneer stem cells and co -founder of many health technologies such as Genomics Company, Human Lonten, Kapp said. They discussed genomics, microbiomes and new technology that was not part of mainstream Medicine.
Inspired, Kapp returned to his homeland in Naples, Florida and “started one thing called longevity.
In March 2020, Diamandis (depicted above) and his friend Tony Robbins listened to the Kapp center and visited. They had a stem cell starting called Fountain Therapeutics. The conversation soon turned to a merger and by October of the same year the two companies became Lively life.
Kapp remained Managing Director with Diamandis and Robbins as co -founders and members of the Board of Directors.
Today his board also includes Hariri as a consultant. Todd Wanek, Managing Director of Ashley Furniture Industries, as an investor. And the rich Indian business Mogul Bk Modi as an investor as well.
TechCrunch event
Francisco
|
27-29 October 2025
Fountain Life tells TechCrunch exclusively that it has just set a series of B $ 18 million, led by EOS Ventures, with the participation of most of the existing board members. Fountain has previously set an A 80 million A series of $ and has raised a total of about $ 108 million, Kapp said.
Longevity as the subject of a serious study by the medical community is a new sector. When Kapp (depicted below) began his center for the first time, “we didn’t know exactly what longevity meant,” he said. But in the last four or five years, much more research has been done.
The first beginning of longevity, he said, is “don’t die of anything stupid.” Therefore, the centers of Fountain Life, of which four exist today, have a great deal of emphasis on prevention control, seeking diseases and chronic diseases in their early stages when they tend to be asymptomatic. Blood tests and body scans collect data on more than 100 biomarkers from liver fat in “germs concentrations”, he said.
The second gentleman is optimization, which means improving these indicators with scientifically validated treatments, he said. And the third gentleman is “using the latest regenerative treatments under FDA tests”, to treat the disease or achieve optimization.
Sorting tests may, for example, discover the bacterial overgrowth of the small bowel (SIBO), which, which has not been treated, can lead to certain cancers, he said. The solution, if caught early, is to restore the balance of germs with specific, prescription microbiotics.
For Fountain members, the tests are repeated about every quarter and patients can monitor the results and ask questions of an AI application called Zori.
But it is expensive, Kapp admitted. A complete subscription costs $ 30,000 a year and $ 10,000 will only cover the test process and AI, but not ongoing tests and medical support.
Still, Kapp remembers two stories that told him that this work was on the right track. The wife of a fan Robbins bought a member of her husband and the tests received an early stage, asymptomatic kidney cancer. The husband is now without cancer.
When the World Hotelier Sam Nazarian explored a collaboration with Fountain Put longevity centers in luxury hotelsNazarian did the trials of the Fountain and found a brain aneurysm. They have successfully treated it, Nazarian has said publicly.
KAPP says the new funding will allow the company to open more centers. Except for Naples. Westchester, New York. Orlando and Dallas, a center in Houston will open in December. The centers in Los Angeles and Miami are designed for the third quarter of 2026.
He hopes to solve the issue of economic accessibility, working in “Clinical Development” where Fountain is training medical facilities in its methodologies. KAPP says that as technology and know -how become widely available, this will reduce the cost of access.
Fountain is not the only start -up launch of longevity driven by a doctor. The famed functional health doctor Mark Hyman has a company called Health function. It offers a package of about 160 blood tests, with surveillance tests every three to six months, for $ 500/year (with additional fees for additional blood tests). Its platform similarly analyzes and monitors the results of the tests, although it does not make full body scans or offers instant access to doctors.
